Establishment reflects the clinical progress of IMM-1-104 and its promise in pancreatic cancer - - Follows recent Orphan Drug designation ... beyond well-known names. Despite being considered ...

Regeneron's oncology platform is poised to be a significant growth driver in the next decade. Read why REGN stock remains a ...

The approval of Libtayo (cemiplimab) in advanced NSCLC is for first-line treatment of patients with 50% or more PD-L1 expression and no EGFR, ALK or ROS1 aberrations, taking the drug into a large ...

Based in Tarrytown, New York, the company’s products include EYLEA, Dupixent, Libtayo, Praluent ... along with other pharmaceutical stocks and drug makers, after President Trump said the ...

Sanofi and Regeneron have reported new data for Libtayo that suggests the drug could be a contender. Overall survival (OS) was 22 months with the combination, compared to 13 months with chemo on ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

Hikma Pharmaceuticals (OTCPK:HKMPF) announced on Thursday that it has acquired the FDA-approved Abbreviated New Drug Application (ANDA) for trametinib tablets, a cancer treatment medication ...

The medication order identifies the desired active moiety by proprietary or generic name along with the duration of treatment. Types of drugs used in compounding are identified. Compounding personnel ...

Approximately half of all respondents reported that their facility uses tall man lettering for similar drug names that appear on pharmacy computer drug selection screens, computer-generated ...

She further alleged that the co-actor was spitting out a white powder-like substance during a rehearsal, suggesting drug use on set. Malayalam actor Sreenath Bhasi withdraws anticipatory bail plea ...

Three popular over-the-counter pain medications have been recalled by Glenmark Pharmaceuticals Inc. USA due to manufacturing issues, according to the Food and Drug Administration. The recalled ...